BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33247713)

  • 1. Metabolic Consequences of Solid Organ Transplantation.
    Bhat M; Usmani SE; Azhie A; Woo M
    Endocr Rev; 2021 Mar; 42(2):171-197. PubMed ID: 33247713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
    Ward HJ
    J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long-Term Survival.
    Azhie A; Sheth P; Hammad A; Woo M; Bhat M
    Liver Transpl; 2021 Oct; 27(10):1468-1478. PubMed ID: 34165872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight gain and cardiovascular risk after organ transplantation.
    Baum CL
    JPEN J Parenter Enteral Nutr; 2001; 25(3):114-9. PubMed ID: 11334060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of different immunosuppressive regimens in the development of posttransplant diabetes mellitus.
    Prokai A; Fekete A; Pasti K; Rusai K; Banki NF; Reusz G; Szabo AJ
    Pediatr Diabetes; 2012 Feb; 13(1):81-91. PubMed ID: 21595806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review.
    Rothbaum Perito E; Lau A; Rhee S; Roberts JP; Rosenthal P
    Liver Transpl; 2012 Sep; 18(9):1009-28. PubMed ID: 22641460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management strategies for posttransplant hypertension.
    Midtvedt K; Neumayer HH
    Transplantation; 2000 Dec; 70(11 Suppl):SS64-9. PubMed ID: 11152234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.
    Gutierrez-Dalmau A; Campistol JM
    Drugs; 2007; 67(8):1167-98. PubMed ID: 17521218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and physiological mechanisms of new-onset diabetes mellitus after solid organ transplantation.
    Dong M; Parsaik AK; Eberhardt NL; Basu A; Cosio FG; Kudva YC
    Diabet Med; 2012 Jul; 29(7):e1-12. PubMed ID: 22364599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplant-associated hyperglycemia.
    Bloom RD; Crutchlow MF
    Transplant Rev (Orlando); 2008 Jan; 22(1):39-51. PubMed ID: 18631857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight gain, overweight and obesity in solid organ transplantation--a study protocol for a systematic literature review.
    Beckmann S; Ivanović N; Drent G; Ruppar T; De Geest S
    Syst Rev; 2015 Jan; 4(1):2. PubMed ID: 25563983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplant malignancy.
    Trofe J; Beebe TM; Buell JF; Hanaway MJ; First MR; Alloway RR; Gross TG; Woodle ES
    Prog Transplant; 2004 Sep; 14(3):193-200. PubMed ID: 15495778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Posttransplant diabetes. Metabolic consequences of posttransplant immunosuppressive treatment].
    Christiansen E
    Ugeskr Laeger; 2007 Jun; 169(24):2309-11. PubMed ID: 17594845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic management of posttransplant diabetes mellitus.
    Mannon RB
    Transplant Rev (Orlando); 2008 Apr; 22(2):116-24. PubMed ID: 18631864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of immunosuppression after liver transplantation.
    Noble J; Terrec F; Malvezzi P; Rostaing L
    Best Pract Res Clin Gastroenterol; 2021; 54-55():101762. PubMed ID: 34874845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New-onset diabetes mellitus after solid organ transplantation.
    Bodziak KA; Hricik DE
    Transpl Int; 2009 May; 22(5):519-30. PubMed ID: 19040489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant diabetes mellitus. The role of immunosuppression.
    Jindal RM; Sidner RA; Milgrom ML
    Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern immunosuppression after solid organ transplantation].
    Beimler J; Morath C; Zeier M
    Internist (Berl); 2014 Feb; 55(2):212-22. PubMed ID: 24518922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive Therapy in Solid Organ Transplantation: Primer for Radiologists and Potential Complications.
    Tammisetti VS; Prasad SR; Dasyam N; Menias CO; Katabathina V
    Radiol Clin North Am; 2023 Sep; 61(5):913-932. PubMed ID: 37495297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting, managing and preventing new-onset diabetes after transplantation.
    Gosmanov AR; Dagogo-Jack S
    Minerva Endocrinol; 2012 Sep; 37(3):233-46. PubMed ID: 22766890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.